BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Chacruna - ECPv6.16.3//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Chacruna
X-ORIGINAL-URL:https://chacruna.net
X-WR-CALDESC:Events for Chacruna
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:UTC
BEGIN:STANDARD
TZOFFSETFROM:+0000
TZOFFSETTO:+0000
TZNAME:UTC
DTSTART:20250101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=UTC:20260617T120000
DTEND;TZID=UTC:20260617T133000
DTSTAMP:20260619T132636
CREATED:20260618T172401Z
LAST-MODIFIED:20260618T172826Z
UID:134444-1781697600-1781703000@chacruna.net
SUMMARY:Psychedelics and the Future of Pain Care
DESCRIPTION:Do you wish you got into this event for free? Become a Chacruna member and receive free or discounted access to all Community Forums\, Courses\, Workshops\, and more! Also get full access to our entire archive of past forum recordings and join our global network of psychedelic professionals and activists to dive deeper into discussion and discovery. \nWe invite you to explore the emerging intersections of psychedelic medicine and chronic pain care in our next Community Forum\, which will examine how psychedelic-assisted approaches to pain may both align with and challenge existing mental health treatment models. As interest in psychedelic therapies continues to grow\, important questions remain about how these interventions work in the context of long-term pain conditions\, and whether current frameworks adequately address the realities faced by people living with chronic pain. We’ll discuss the mechanisms through which psychedelics may influence pain\, whether by reducing pain itself\, transforming the relationship individuals have with pain\, or improving overall quality of life. What role do factors such as dose\, intensity of experience\, and therapeutic support play in pain outcomes? Do all patients benefit from traditional talk-therapy models as part of care? And as the field advances\, how can clinicians\, researchers\, educators\, and patient advocates work together to develop responsible\, evidence-based models of care? We’ll also discuss the key issue of how to communicate both the promise and the limitations of psychedelic therapies without creating unrealistic expectations for those living with serious pain. You’ll hear from Joe Moore\, co-founder and CEO of Psychedelics Today; Tess Veuthey\, neurologist and pain physician; and Jagpaul Kaur Deol\, Clinical Advisor with TheraPsil and member of MAPS Canada Board of Directors; in a conversation moderated by Lorien Chavez\, Development and Operations Officer for the Chacruna Institute.
URL:https://chacruna.net/event/psychedelics-and-the-future-of-pain-care/
LOCATION:Virtual
CATEGORIES:Community Forum
ATTACH;FMTTYPE=image/webp:https://chacruna.net/wp-content/uploads/2026/06/cover-photo-1781199716171.webp
END:VEVENT
END:VCALENDAR